Cargando…
Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related death worldwide, which lacks effective inhibition of progression and metastasis in the advanced clinical stage. Mesoporous silica nanoparticle (MSN)–based cytotoxic or immunoregulatory drug–loading strategies have attracted wid...
Autores principales: | Wu, Han, Xu, Xin-Fei, Zhu, Jia-Qi, Wang, Ming-Da, Li, Chao, Liang, Lei, Xing, Hao, Wu, Meng-Chao, Shen, Feng, Huang, Dong-Sheng, Yang, Tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531639/ https://www.ncbi.nlm.nih.gov/pubmed/34692650 http://dx.doi.org/10.3389/fbioe.2021.695635 |
Ejemplares similares
-
Mesoporous Silica Nanoparticle-Based Imaging Agents for Hepatocellular Carcinoma Detection
por: Peng, Xuqi, et al.
Publicado: (2021) -
Efficient Photoacoustic Imaging With Biomimetic Mesoporous Silica-Based Nanoparticles
por: Huang, Chuangjia, et al.
Publicado: (2021) -
Modified hollow mesoporous silica nanoparticles as immune adjuvant-nanocarriers for photodynamically enhanced cancer immunotherapy
por: Li, Qianru, et al.
Publicado: (2022) -
Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances
por: Tao, Yaoye, et al.
Publicado: (2020) -
Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy
por: Chaudhary, Zanib, et al.
Publicado: (2019)